Regeneron 2416 Cat Study

If you are interested in participating in this clinical trial, please fill out the contact form below to speak to one of our Research Coordinators to find out if this study is right for you.

This study aims to demonstrate how well REGN1908-1909 works in reducing ocular allergy signs and symptoms in participants with cat allergy. Adult participants aged 18 years and older will be considered for participation if they are unable to tolerate being around a cat due to moderate to severe cat allergy symptoms.

To be eligible for this study, you must be:

  • 18 years of age or older

  • In good health

  • Documented or participant-reported history of moderate to severe cat allergy for at least 2 years with bothersome ocular symptoms being near cat(s).

This is not a complete list of eligibility criteria. The study doctor will review the full entry criteria for this study with you.

Please complete the form below if you are interested in learning more about this study. If eligible, someone from our clinical trial team will contact you with additional questions and more details about the trial.

Please note that only eligible respondents will be contacted to participate in the trial.